- Home
- USIO vs DXR Comparison
USIO vs DXR Comparison
Compare USIO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USIO
- DXR
- Stock Information
- Founded
- USIO 1998
- DXR 1970
- Country
- USIO United States
- DXR United States
- Employees
- USIO N/A
- DXR N/A
- Industry
- USIO Investment Bankers/Brokers/Service
- DXR Medical/Dental Instruments
- Sector
- USIO Finance
- DXR Health Care
- Exchange
- USIO Nasdaq
- DXR Nasdaq
- Market Cap
- USIO 36.6M
- DXR 40.3M
- IPO Year
- USIO N/A
- DXR N/A
- Fundamental
- Price
- USIO $1.52
- DXR $7.41
- Analyst Decision
- USIO Strong Buy
- DXR Strong Buy
- Analyst Count
- USIO 2
- DXR 1
- Target Price
- USIO $5.00
- DXR $25.00
- AVG Volume (30 Days)
- USIO 120.6K
- DXR 5.1K
- Earning Date
- USIO 05-14-2025
- DXR 01-01-0001
- Dividend Yield
- USIO N/A
- DXR N/A
- EPS Growth
- USIO N/A
- DXR 86.16
- EPS
- USIO 0.12
- DXR 0.11
- Revenue
- USIO $82,931,840.00
- DXR $119,714.00
- Revenue This Year
- USIO $16.14
- DXR N/A
- Revenue Next Year
- USIO $13.51
- DXR N/A
- P/E Ratio
- USIO $12.67
- DXR $68.18
- Revenue Growth
- USIO N/A
- DXR N/A
- 52 Week Low
- USIO $1.24
- DXR $6.55
- 52 Week High
- USIO $2.92
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- USIO 52.89
- DXR 40.41
- Support Level
- USIO $1.24
- DXR $7.38
- Resistance Level
- USIO $1.57
- DXR $8.19
- Average True Range (ATR)
- USIO 0.11
- DXR 0.40
- MACD
- USIO 0.02
- DXR -0.05
- Stochastic Oscillator
- USIO 84.85
- DXR 17.65
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.